Health Economics and HTA and its role in pricing and reimbursement, pipeline and in-lisencing evaluations as well as portfolio and company valuations in the biotech and pharmaceutical sector is ever increasing. While I was searching the web for various news on the topic, I actually couldn't find a blog that offers a platform of exchange among professionals in this field around the various topics - so there we go now and I hope you enjoy the information... Cheers Ulf
11.13.2007
Health Economics survey of European hospital pharmacies
An interesting survey has been conducted by Caro Research Institute with EU hospital pharmacists. As they are vital in hospital formulary decision making in many countries it appears that they could benefit from expanded knowledge about health economics in order to fully appreciate the dosiers presented to them. The authors of the survey encourage pharmaceutical companies to make a greater effort to collaborate with clinical experts in the dissemination of economic data in timely and transparent drug reviews.
No comments:
Post a Comment